Tailoring The Experimental Validation Workflow To Leverage Ultra-Large Virtual Screening For Accelerated Discovery Of Therapeutics
Time: 4:30 pm
day: Day 1
Details:
- Structure-based virtual screening is evolving to be a key tool in early drug discovery, with increasing interest in screening multi-billion compound libraries
- Integrating biophysical, biochemical, cellular and structural components of the validation workflow, coupled with computational drug design can accelerate hit validation and triaging
- Delve into the unique benefits and challenges of a virtual-screening driven validation and lead optimization workflow
